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Summary 
L-sdectin is a lectin-like receptor that mediates the attachment of lymphocytes to high endothelial 
venules (HEV) of lymph nodes during the process of lymphocyte recirculation. Two sulfated, 
mucin-like glycoproteins known as Sgp50/GlyCAM-1 and Sgp90/CD34 have previously been 
identified as HEV-associated ligands for L-selectin. These proteins were originally detected with 
an L-selectin/Ig chimera called LEC-IgG. GIyCAM-1 and CD34 are also recognized by an anti- 
peripheral node addressin  (PNAd) mAb called MECA 79, which blocks L-selectin-dependent 
adhesion and selectively stains lymph node HEV. The present study compares the requirements 
for the binding of MECA 79 and LEC-IgG to HEV-ligands. Whereas desialylation of GlyCAM-1 
and CD34 drastically  reduced binding to LEC-IgG, this treatment enhanced the binding of 
GlyCAM-1 to MECA 79. In contrast, the binding of both MECA 79 and LEC-IgG to GlyCAM-1 
and CD34 was greatly decreased when the sulfation of these ligands was reduced with chlorate, 
a metabolic inhibitor of sulfation.  Because MECA 79 stains HEV-like vessels at various  sites 
of inflammation, recognition by L-selectin of ligands outside of secondary lymphoid organs may 
depend on sulfation.  In addition to their reactivity with GlyCAM-1 and CD34, both MECA 
79 and LEC-IgG recognize an independent molecule of ~200 kD in a sulfate-dependent manner. 
Thus, this molecule, which we designate Sgp200, is an additional ligand for L-selectin. 
selectin, originally identified on mouse lymphocytes by 
the mAb MEL-14  (1, 2),  mediates the attachment of 
lymphocytes to high endothelial venules (HEV) 1 of lymph 
nodes during the process of lymphocyte recirculation. The 
widespread distribution of L-selectin on all leukocyte classes 
underlies its more general participation in leukocyte-endo- 
thelial interactions during a variety of inflammatory reactions 
(3-5). A potential role for L-selectin in the pathophysiologic 
targeting of leukocytes to certain extravascular sites has also 
been proposed (6). As a member of the selectin family of 
cell-cell  adhesion proteins, L-selectin  contains an extracel- 
lular calcium-type lectin domain (7), which dictates its adhe- 
sive function (8-11). The preferential involvement of L-selectin 
in lymphocyte trafficking to lymph nodes, as opposed to 
mucosal lymphoid organs such as Peyer's patches (12), origi- 
nally motivated the search for cognate HEV-ligands that are 
1 Abbreviations  used in this paper: AAA, Aleuria aurantia agglutinin; HEV, 
high endothelial venule; LEC-IgG, mouse L-selectin/Ig chimeric  receptor; 
LFA, Limax flavus  agglutinin; PLN,  peripheral lymph node; PNAd, 
peripheral lymph node vascular addressin; Sgp, sulfated glycoprotein. 
distributed in an organ-specific  manner. Two different ap- 
proaches have been employed to identity such ligands.  One 
approach has used an immunoglobulin chimera of L-selectin, 
designated mouse L-selectin/Ig chimeric receptor or LEC- 
IgG, as a soluble receptor analogue (13). LEC-IgG selectively 
stains HEV in lymph nodes sections and blocks lymphocyte 
attachment to lymph node HEV (13). Employing this chi- 
mera as an affinity reagent, Imai et al. (14) precipitated two 
glycoproteins of '~50 and "~90 kD from lymph nodes that 
had been metabolically labeled with [358]$04. These two 
ligands, originally designated as sulfated glycoprotein (Sgp)50 
and Sgpg0, were subsequently identified at the molecular level 
as GIyCAM-1 (15) and a HEV-specific glycoform of CD34 
(16). GlyCAM-1 is a secreted glycoprotein that may also have 
a peripheral membrane association  with the apical plasma 
membrane of HEV endothelial cells (15, 17), whereas CD34 
is a transmembrane glycoprotein found on endothelial cells 
and hematopoietic stem cells  (18). Both GIyCAM-1  and 
Sgp90/CD34 are mucin-like glycoproteins that bear sulfated, 
sialylated, and fucosylated O-linked carbohydrate chains (14). 
For both ligands,  sialylation  is essential for recognition by 
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or in vitro desialylation of HEV markedly reduces lympho- 
cyte attachment (20, 21). Although fucosylation has not been 
directly demonstrated as an essential modification of these 
ligands,  its importance is strongly suspected based on the 
observation that sialyl Lewis X, although a very weak inhib- 
itor/ligand (19, 22, 23) for L-selectin, is superior to 3' sialyl 
lactose (neu5Acot2 -~ 3Gal/31 --- 4Glc) (19), which differs 
only in its lack of fucose. Also,  an essential  role for fucose 
has been established for the myeloid ligands of both P- and 
E-selectin (24),  which possess calcium-type lectin domains 
that are highly homologous to that of L-selectin (8, 9). Fi- 
nally, HEV express binding sites for E-selectin (25), CSLEX 
mAb (26),  and HECA 452 mAb (22),  whose carbohydrate 
epitopes all require fucose. 
Sulfation  has  long been  suspected  to  be  an  important 
modification of lymph node HEV-ligands, stemming from 
the original observation that lymph node HEV are sites of 
avid  incorporation of [358]S04 into  macromolecules (27). 
Additional interest in the sulfation of HEV-ligands has de- 
rived from the knowledge that several sulfated glycoconjugates, 
although completely lacking in sialylation, exhibit specific 
ligand activity for L-selectin (28-33).  A direct role for the 
sulfation of GlyCAM-1 was first demonstrated using chlo- 
rate, a highly selective metabolic inhibitor of sulfation (34). 
Undersulfated GlyCAM-1, produced in organ culture of lymph 
nodes with  chlorate present,  shows  dramatically reduced 
binding to L-selectin. Direct analysis of the GlyCAM-1 car- 
bohydrates has been undertaken with the objective of defining 
a minimal recognition determinant that accommodates the re- 
quirements for sialylation, fucosylation, and sulfation (35-37). 
An independent approach to the identification of HEV- 
ligands for L-selectin has relied on the use ofa mAb strategy. 
Streeter et al. (38) described an anti-peripheral lymph node 
(PLN) addressin mAb (i.e., MECA 79) that stains lymph node 
HEV and blocks L-selectin-dependent lymphocyte attach- 
ment both in vitro and in vivo. In contrast, the luminal staining 
of HEV in Peyer's patches is weak, consistent with the lesser 
role of L-selectin at this site (38, 39). The function-blocking 
activity of MECA 79 has recently been extended to HEV 
in human lymph nodes and tonsils (40).  By Western blot- 
ting  or  radioiodination  of immunoprecipitated  material, 
MECA 79 reacts with a complex set of proteins in both human 
tonsils and mouse lymph nodes (41, 42). It is important to 
note that GlyCAM-1 and CD34, as isolated with LEC-IgG 
from mouse lymph nodes, carry the epitope for MECA 79 
(14). Moreover, the set of MECA 79-precipitated bands (de- 
tected by radioiodination) from lymph nodes of young mice 
includes components at •50  and '~90 kD as well as five ad- 
ditional species (42) (see Discussion). The isolated complex 
of MECA 79-reactive proteins (PLN addressin [PNAd]) is 
able to support specific lymphocyte attachment via L-selectin 
in a sialidase-sensitive  manner (41). The occurrence of the 
MECA 79 epitope on multiple components has suggested 
that it might represent a carbohydrate posttranslational mod- 
ification closely associated with the determinants that confer 
binding activity for L-selectin (41).  Although the MECA 
79-defined modification has clearcut functional significance, 
as adduced from the function-blocking activity of the anti- 
body and the adhesion-promoting activity of the PNAd com- 
plex,  the biochemical nature of the epitope has heretofore 
not been examined. 
In this study, we show that both L-selectin and MECA 
79  mAb  recognize  the  same  set  of [3H]Gal-labeled  and 
[35S]SO4-1abeled glycoproteins from lymph nodes. Further- 
more, we show that as for L-selectin, recognition of these 
HEV-ligands by MECA  79 is dependent on sulfation. 
Materials and Methods 
Materials.  LEC-IgG was provided by Dr. L. Lasky and Dr. S. 
Watson (Genentech Inc., South San Francisco, CA) and immobi- 
lized on protein A-Sepharose  4B (Zymed Laboratories, Inc., South 
San Francisco, CA) at 10 mg/ml of gel. The rabbit polyclonal anti- 
serum CAM02 against an internal peptide (peptide 2) of GlyCAM-1 
has been described (15). Rabbit antiserum directed against recom- 
binant murine CD34 (16) was a gift of Dr. L. Lasky and Dr. S. 
Baumhueter. Rabbit antibodies and preimmune serum were cova- 
lently  cross-linked with  dimethylpimelimidate (43) to  protein 
A-Sepharose after saturating the protein A with serum. MECA 
79 mAb (rat IgM) and a control rat IgM mAb (OZ42), described 
previously  (38), were immobilized to a substitution level  of 2 mg/ml 
gel on anti-rat Ig Sepharose (Sigma  Chemical Co., St. Louis, MO). 
CAM02-peptide (CKEPSIFREELISKD) was synthesized by Dr. 
C. Glabe of the University of California (Irvine, CA). Limaxflavus 
agglutinin  was purchased from Calbiochem-Novabiochem (San 
Diego, CA). Recombinant Aleuria aurantia agglutinin (AAA) was 
the gift of Dr. A. Kobata and Dr. T. Endo (University of Tokyo, 
Tokyo,  Japan). Both lectins were immobilized on CNBr-activated 
Sepharose 4B (Sigma Chemical Co.) at a level of 2 mg lectin/ml 
gel (44). 
Metabolic Labeling of Murine Lymph Nodes.  Murine  axillary, 
brachial, cervical, and mesenteric lymph nodes from five ICR mice 
were split into two equal parts and labeled in parallel in organ cul- 
ture (0.5 ml RPMI 1640, 4 h, 37~  each containing 0.5 mCi/ml 
o-[6-3H]galactose (Du Pont-NEN,  Boston, MA). In one of the 
two cultures, sulfate content was depleted to 1/10 of normal and 
10 mM sodium chlorate was added as an inhibitor of sulfation. 
For labeling with [3ss]so4, lymph nodes from five mice were la- 
beled in organ culture (4 h, 37~  in 1 ml RPMI 1640 with sulfate 
depleted to 1/10 normal and Na23sso4 (ICN, Irvine, CA) added 
at 1 mCi/ml. 
Immunoprecipitations.  To generate cell lysates, labeled tissues 
from control or chlorate-treated cultures were washed with 1 ml 
Dulbecco's PBS and then homogenized in 1 ml of PBS with 2% 
Triton X-100 supplemented with leupeptin (10/~g/ml), pepstatin 
A (10 #g/ml), aprotinin (0.28 U/ml trypsin inhibitor), benzami- 
dine (0.75 mM), and PMSF (1 mM). Homogenates were centrifuged 
(5 min, 10,000 g) and supernatants precleared by 18 h incubation 
with 50/xl preimmune Ig-agarose. The supernatants were then im- 
munoprecipitated  sequentially (4  h/immunoprecipitation)  with 
10/~1 of CD34 Ab-agarose followed by 20 #1 of CAMO2 Ab- 
agarose. The immunoprecipitates were washed 5x  with 1.5 ml 
of PBS containing 0.25%  Triton X-100 and then boiled (5 rain) 
in 0.4 ml of this buffer. For reprecipitation, each antigen prepara- 
tion was split into four 100/~1 aiiquots. Three of the aliquots were 
incubated in parallel (4 h) with 2.5/xl LEC-IgG matrix (+ 2 mM 
CaC12),  5 /~1 MECA  79-agarose,  or 5  /zl Limax flavus agglu- 
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/~1 3 x  concentrated reducing SDS-sample buffer. Matrices were 
washed 4x  with 0.5 ml of PBS containing 0.25% Triton X-100 
and  boiled  in  reducing  SDS-sample buffer  (150 /zl  final) for 
SDS-PAGE. 
Lysates  were also  directly precipitated with LEC-IgG or MECA 
79. Lysates  prepared as above were precleared with 50 #1 protein 
A-agarose and then precipitated with 10/zl of LEC-IgG matrix 
or alternatively  were precleared  with 10/zl OZ42-agarose  plus 40 #1 
protein  A-agarose and then precipitated with 10 #1 of MECA 
79-agarose. Precipitates  were washed  5 x with 1.5 ml of  PBS 0.25% 
Triton X-100. The LEC-IgG matrix was eluted with 100/~1 Tris- 
buffered saline (TBS; 10 mM Tris-C1, 150 mM NaC1, pH 7.4) con- 
taining 5 mM EDTA, whereas the MECA 79 matrix was eluted 
by boiling in  100/~1 of reducing SDS-sample buffer. 
Exoglycosidase Digestions of GlyCAM-I.  Conditioned medium 
was collected from the organ cultures above (cultured in the pres- 
ence or absence of chlorate), and clarified  by brief centrifugation 
(10,000 g, 5 min). After preclearing  with 50/zl protein A-Sepharose, 
the conditioned  medium  was  immunoprecipitated with 25  /zl 
CAMO2 Ab-agarose. The beads were washed 5 x  with 1.5 ml 
of TBS and eluted with 1 mg/ml of CAMO2-peptide  in TBS 
(200/~1). 10/zl aliquots of the eluate were reacted with 25 mU 
ofArtkrobacter ureafaciens  sialidase  (Calbiochem-Novabiochem)  alone 
or with the sialidase combined with 5/zU of Streptomyces sp142 
c~(1--~3/4) fucosidase  (Takara  Shuzo Co., Berkeley,  CA) in 50 mM 
Na-cacodylate (pH 6.0), 0.05% BSA, 0.05% NAN3, and 0.125% 
Triton X-100 (final  volume 50/zl) for 48 h at 37~  A control sample 
was incubated in parallel (48 h, 37~  in buffer only. Each of the 
digests and the control  sample were then split into four equal 
(12.5/zl) parts, of which three were diluted to 300/zl with PBS 
containing 0.1% BSA, 0.25%  Triton X-100, and 0.02%  NAN3, 
while the fourth was boiled in reducing SDS-sample  buffer (100/~1 
final). The three aliquots were then reprecipitated with 10/zl of 
either  MECA  79-agarose, Limax flavus  agglutinin-agarose,  or 
AAA-agarose. Matrices were washed 4 x  with 0.5 ml of PBS con- 
taining 0.25%  Triton X-100 and boiled in reducing SDS-sample 
buffer (100/zl  final) for SDS-PAGE. 
SDS-PAGE.  SDS-PAGE  (10% polyacrylamide gels) was car- 
ried out as described by Laemmli (45). 
combination ofArthrobacter sialidase and Streptomyres c~(1-~3/ 
4) fucosidase. We previously demonstrated that this fucosidase 
removes '~70% of total fucose from desialylated GlyCAM-1 
but is inactive on sialylated GlyCAM-1 (36). We confirmed 
that sialidase/fucosidase-treatment of [3H]galactose-labeled 
GlyCAM-1 removed a substantial fraction of  fucose, as shown 
by the 89% reduction in binding to AAA (Table 1, Fig.  1), 
a fucose-specific lectin (46). MECA 79 binding to sialidase/ 
fucosidase-treated GlyCAM-1 was reduced 26% relative  to 
its binding to sialidase-treated  GlyCAM-1 (Table 1, Fig.  1). 
In  an  independent  experiment,  a  reduction  of 35%  was 
observed. 
The possible  importance of sulfate to the MECA 79 epi- 
tope was investigated using chlorate as a metabolic inhibitor 
of sulfation. We previously devised conditions that suppress 
the sulfation of GIyCAM-1 and other macromolecules within 
lymph nodes by ",,90% without affecting the overall sialyla- 
tion or fucosylation of GlyCAM-1 or altering the pattern 
of protein synthesis within the nodes (34). As shown in Fig. 
2,  undersulfated [3H]galactose-labeled  GlyCAM-1 showed 
undiminished binding to CAMO2 or to Limaxflavus agglu- 
tinin. The decreased mobility of undersulfated GlyCAM-1 
on SDS-PAGE may reflect the strong contribution of sulfa- 
tion to the overall charge of the glycoprotein. In correspon- 
dence with previous  results obtained with other metabolic 
Results 
We first examined the possible contribution of sialylation 
and fucosylation to the MECA 79 epitope on GlyCAM-L 
GlyCAM-1 was metabolically labeled with [3H]galactose in 
lymph node organ cultures and was isolated from conditioned 
medium with CAM02, a polyclonal antibody directed to an 
internal peptide sequence of GlyCAM-1 (15). To remove sialic 
acid, the isolated glycoprotein was treated with a broad spec- 
trum sialidase from A.  ureafaciens. As shown in Fig.  1 and 
Table 1, desialylation was effective, since the treated glyco- 
protein completely lost its reactivity with Limax agglutinin, 
a lectin with broad specificity for sialic acid (44). Desialylated 
GlyCAM-1 retained its ability to bind to MECA 79 mAb, 
as seen by visual inspection of the gel (Fig. 1). In fact, quan- 
titation  by  densitometry  revealed  significantly increased 
("~70%) binding of MECA 79 to desialylated GlyCAM-1 
as compared with normal GIyCAM-1. 
To remove fucose, isolated GlyCAM-1 was treated with a 
Figure 1.  Effects  of sialidase and sialidase/fucosidase  treatments of 
GIyCAM-1  on binding  to MECA 79. GlyCAM-1,  labeled  with pH]galac- 
rose and isolated  with CAM02  antibody,  was either  not treated  (normal), 
digested  with Aahrobacter  sialidase  (desialylated),  or digested  with combined 
Arthrobacter  sialidase  and Streptomyces  ~(1---~3/4) fucosidase  (desialylated/ 
defucosylated).  Each GIyCAM-1  preparation  was divided  into four  equal 
aliquots, of  which  three  were subjected  to precipitation  with AAA,  a lectin 
with specificity  for fucose  moieties;  Limaxflavus  agglutinin  (LFA),  a tectin 
with specificity  for sialic  acid  moieties,  and MECA  79 (M79). The precipi- 
tates and the fourth  aliquot  of  each  preparation  containing  the total  CAM02- 
reactive GlyCAM-1  (T) were run on a 10% SDS gel. The gel was ana- 
lyzed by autoradiography. 
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Sialidase/ 
Untreated  Sialidase  c~(1-'~3/4)  Fucosidase 
Fraction  Amount  Percent  total  Amount  Percent  total  Amount  Percent  total 
MECA  79-bound  2194  30  2695  52  1719  38 
Limax-bound  5491  74  0  0  3  0 
AAA-bound  7096  96  5095  99  501  11 
Tot~ input  (T)  7363  100  5150  100  4569  100 
The data presented in the table were obtained by densitometry  (Molecular Dynamics, Sunnyvale, CA) of the autoradiograph depicted in Fig.  1. 
In this analysis, the region of the autoradiograph limited at the upper end by the 66-kD marker and at the lower end by the 31-kD marker was 
divided into twelve parallel segments containing the GlyCAM-1 bands of the  12 lanes in the gel. The amount of GlyCAM-1 in each lane (given 
in arbitrary units) was obtained by integration of the optical density over the entire respective segment with subtraction of the background.  Each 
value is given as a percentage of total GlyCAM-1, with total (T) defined as the amount  of CAM02-reactive GlyCAM-1 in the respective sample. 
labels  (34),  the undersulfated  GlyCAM-1  exhibited  no  de- 
tectable binding to LEC-IgG. Furthermore, MECA 79 mAb 
failed to precipitate undersulfated  GlyCAM-1.  It should be 
noted that only a subset of the Ab-precipitated GlyCAM-1 
was capable of reacting with either LEC-IgG or MECA 79, 
despite the fact that these reagents were used in great excess. 
The  LEC-IgG reactive  subset  and,  to  a  lesser  degree,  the 
MECA  79-reactive  subset  corresponded  to  the  higher  Mr 
species of the  glycoprotein. 
Sulfation  dependence  was also investigated with  [3H]ga- 
lactose-labeled CD34 isolated from cultured lymph nodes (Fig. 
3).  Undersulfation  did not  affect the recognition  of CD34 
by either the anti-CD34 Ab or Limax agglutinin.  However, 
the binding of undersulfated CD34 to LEC-IgG or to MECA 
79 was almost completely abrogated.  Again,  the MECA 79 
and LEC-IgG reactive species occurred in a higher Mr subset 
of the total CD34, as defined by precipitation with the poly- 
clonal  CD34  Ab. 
To directly compare components  from lymph node that 
were reactive with MECA 79 and LEC-IgG, a detergent lysate 
Figure  2.  Sulfate  dependency of LEC-IgG and MECA 79 interaction 
with GlyCAM-1. Lymph nodes were labeled with [3H]galactose  in the 
presence or absence  of sodium chlorate, and GlyCAM-1 was isolated with 
CAM02 antibody from a detergent lysate. Antigen from each culture was 
released from the antibody-beads by specific  peptide elution and divided 
into four equal aliquots. One aliquot (anti-GlyCAM-1) was not subjected 
to further precipitation while the other three aliquots were precipitated 
with beads conjugated to Limax agglutinin, MECA 79, or LEC-IgG. The 
four samples from each culture condition were electrophoresed on a 10% 
SDS gel and the gel was analyzed by autoradiography. 
Figure  3.  Sulfate dependency of LEC-IgG and MECA 79 interaction 
with CD34/Sgp90. CD34/Sgp90 was isolated with CD34 antibody from 
detergent lysates of lymph node cultures, labeled with [3H]galactose in 
the presence or absence of sodium chlorate. Antigen from each culture 
was released from the antibody beads by boiling and divided into four 
equal aliquots. One aliquot (anti-CD34) was not subjected  to further precipi- 
tation while the other three aliquots were precipitated with beads con- 
jugated with Limax  agglutinin, MECA 79, or LEC-IgG. The four samples 
from each culture condition were electrophoresed on a 10% SDS gel and 
the gel was analyzed by autoradiography. 
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79 and LEC-IgG.  Lymph  nodes  (peripheral and mesenteric)  were labeled 
in organ culture  with [3sS]SO4. Equal  aliquots of the detergent lysate  were 
precipitated  with beads conjugated  to Ig control (a mixture  of CD4-IgG 
and rat IgM), MECA 79, LEC-IgG, anti-CD34, or anti-GlyCAM-1 
(CAM02). The precipitates  were electrophoresed  on a 7.5% SDS gel and 
the gel was analyzed  by autoradiograpby.  The double arrowsheads denote 
the bands  corresponding  to Sgp200, CD34/Sgpg0, and GlyCAM-1/Sgp50 
whereas the single arrowhead  denotes  the ,'~170-kD  component.  In the LEC- 
IgG precipitate, the CD34 component is somewhat  compressed due to 
the presence of unlabeled LEC-IgG at "o90 kD. 
of [3sS]SO4-1abded lymph nodes was subjected to precipita- 
tion with the two reagents. Both MECA 79 and LEC-IgG 
precipitated three major bands at ~50, ~90, and ~200 kD 
(Fig. 4). The first two components comigrated with GIyCAM-1 
and CD34/Sgp90,  as shown by precipitation with mono- 
specific polyclonal Abs.  The "~200-kD  component was ap- 
parently distinct, since it was not precipitated by either CAM02 
or CD34 Ab (Fig. 4). A relatively minor band at ',,170 kD 
was also precipitated by both LEC-IgG and MECA 79 but 
not by CAM02 or CD34  Ab. 
To examine the sulfate dependency of precipitation, lymph 
nodes were labeled  in organ culture with [3H]galactose  in 
the presence  or absence of chlorate. Detergent lysates from 
these cultures were reacted in parallel  with LEC-IgG and 
MECA 79. From control lymph nodes, each precipitated the 
same four bands, corresponding to CD34, GIyCAM-1, and 
the "~200 and '~170 kD components (Fig.  5).  Culture of 
lymph nodes in chlorate dramatically reduced or eliminated 
the ability of both LEC-IgG and MECA 79  to recognize 
GlyCAM-1, CD34, and the *200-kD component (Fig. 5). 
In contrast, the recognition of the "~  170-kD component from 
chlorate-treated cultures was largely preserved.  Besides the 
four components that were precipitated in common by the 
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Figure  5.  Sulfate  dependency  of LEC-IgG  and MECA 79 interaction 
with Sgp200. Lymph  nodes (peripheral and mesenteric)  were labeled  in 
organ culture  with [3H]galactose  in the presence or absence of chlorate. 
The detergent  lysates  from  control  and chlorate-treated  cultmes  were  divided 
into equal aliquots and precipitated with MECA 79 or LEC-IgG. The 
precipitates  were  dectrophoresed  on a 10% SDS gd and the gel was analyzed 
by autoradiography.  The double  arrowheads  indicate  the bands corresponding 
to Sgp200, CD34, and GlyCAM-1,  all of  which show  sulfate-dependency 
in their  binding  to LEC-IgG  and MECA  79. The single  arrowhead denotes 
the '~170-kD component. 
two reagents, all of which were relatively diffuse in character, 
a number of sharp bands were precipitated by MECA 79 (Fig. 
5). These bands were judged to be nonspecific components, 
since they were not reprodudbly present in repeat experiments. 
Discussion 
Our  analysis  revealed  that  several [35S]SO4  and  [3H]ga- 
lactose-labeled glycoproteins within lymph node lysates were 
precipitated in common by MECA  79  and LEC-IgG i.e., 
GlyCAM-1, CD34, •200  kD, and an additional component 
at '~170 kD. Previous  analyses of MECA 79-reactive com- 
ponents, employing radioiodination of immunoprecipitated 
material, detected bands corresponding in molecular weight 
to these four components as well as species at 115, 75, and 
"~60 kD  (42). 
The "~60-kD  molecule is of particular interest, because 
it constitutes a subset of MAdCAM-1, a novel glycoprotein 
possessing  both Ig-like domains and a mucin domain (42, 47). MAdCAM-1 was originally identified on HEV of mouse 
Peyer's patches, but it is also present on HEV of mesenteric 
lymph nodes and peripheral  lymph nodes of young mice 
(42, 48). MAdCAM-1 on Peyer's patch HEV is a ligand for 
c~4fl7, a Peyer's patch homing receptor on lymphocytes (49). 
This adhesive function involves its NH2-terminal Ig-like do- 
main (Briskin, M., and E. C. Butcher, manuscript in prepa- 
ration). It is important to note that a MECA 79-reactive  subset 
of MAdCAM-1 on HEV of lymph nodes is recognized by 
L-selectin and can support L-selectin-dependent lymphocyte 
rolling (42). Using MECA 79 and LEC-IgG,  we were un- 
able to detect an obvious "~60 kD component with either 
[3H]galactose  or  [35S]804 as the metabolic label. The domi- 
nance of GlyCAM-1 in the 50-60 kD range may have ob- 
scured a weak MAdCAM-1 band. In fact, in separate studies 
using MECA 367 mAb (47)to precipitate MAdCAM-1 from 
[3ss]so4-1abeled mesenteric lymph nodes, we confirmed that 
MAdCAM-1 incorporated label, although weakly (Veals, S., 
and S. Hemmerich, unpublished observations). The limited 
detectability of this component with MECA 79 and LEC- 
IgG in our metabolic radiolabeling studies, as opposed to its 
ready detectability in radioiodination  and Western blotting 
analyses (42), could be due to a low content of sulfate and 
galactose and/or a slow metabolic turnover. Similar consider- 
ations can be invoked to explain the absence of the 75- and 
115-kD components in our analysis. 
Our experiments demonstrate that LEC-IgG and MECA 
79 both react with a major lymph node component at •200 
kD. Because of the evidence implicating  this component as 
an independent HEV-associated ligand for L-selectin (sum- 
marized below), we designate it as Sgp200. A similar com- 
ponent was identified in the previous analyses  carried out with 
MECA 79 (42). Also, a molecule of "~ 190 kD was detected 
in rat lymph nodes with a rat L-selectin/Ig chimera (50) and 
a *250 kD component was detected in human tonsilar HEV 
with a antibody directed to a complex form of sialyl Lewis 
X (51). Sgp200 closely  corresponds in behavior to GIyCAM-1 
and CD34.  Desialylation of Sgp200 severely reduced its in- 
teraction with LEC-IgG, while allowing its binding to MECA 
79 (data not shown).  However, the binding of Sgp200 to 
both LEC-IgG and MECA 79 was dependent on sulfation. 
Sgp200 did not appear to be an aggregate of  either GlyCAM-1 
or CD34,  since antibodies  against  these ligands  failed to 
precipitate it. Because the LEC-IgG staining of lymph nodes 
is largely restricted to HEV (13), we expect that Sgp200, like 
GlyCAM-1 and the L-selectin reactive form of CD34, will 
also be localized to HEV. 
It is noteworthy that mucin domains are present within 
the  three  molecularly  characterized  glycoproteins  (i.e, 
GlyCAM-1, CD34, and MAdCAM-1) that can function as 
ligands for L-selectin. Additionally, a recently described my- 
eloid ligand for P-selectin has a large mucin-like domain (52). 
It seems quite plausible that the multivalent presentation of 
carbohydrate chains, inherent in this structural organization, 
is an important feature in defining the avidity of these ligands. 
We therefore, predict that Sgp200 will also be mucin-like. 
A major challenge for the future will be to determine the 
physiologic roles of the different L-selectin ligands. 
The distribution of the MECA 79 epitope on multiple com- 
ponents has suggested that it represents a posttranslational 
modification (41). Since  the antibody functionally  blocks ligand 
sites for L-selectin, the most obvious possibility was that the 
epitope consists of a carbohydrate or modification of a carbo- 
hydrate. We have shown here that the sialylation  of GlyCAM-1 
and CD34 is not required for MECA 79 recognition, although 
it is essential for the avid interaction of each with L-selectin. 
In contrast to'sialic acid, fucose appears to contribute posi- 
tively to the MECA 79 epitope. We observed a "~30% reduc- 
tion of MECA 79 binding to GlyCAM-1 following ,x,70% 
removal of fucose. It remains to be seen whether more com- 
plete defucosylation would result in a complete loss of the 
epitope. The most striking finding of the present  study is 
that sulfation is critical for the MECA 79 epitope. Undersul- 
fated GlyCAM-1, CD34, and Sgp200, created by the use of 
chlorate, were not recognized by MECA 79. Furthermore, 
as previously shown for GlyCAM-1 and now extended to 
CD34 and Sgp200, ligand activity for L-selectin was dramat- 
ically reduced by undersulfation. 
The exact nature of the MECA 79 epitope remains to be 
defined. In our previous work, we identified the major sul- 
fated mono- and disaccharides of GlyCAM-1 as Gal-6-SO4, 
GlcNAc-6-SO4,  (SO4-6)Galfll--*4GlcNAc  and  Galfll--~4 
(SO4-6)GIcNAc (36). Furthermore, we showed (37) that a 
major capping group of the GlyCAM-1 O-linked chains is 
6'-sulfated,  sialyl Lewis X, i.e., Siaot2--~3(SO4-6)Gal~l--~4 
(Fucotl-~3)GlcNAc.  The finding that MECA 79 reacts only 
with a subset of GlyCAM-1 and CD34,  as described also 
for MAdCAM-1 (42), suggests that the epitope for this mAb 
may be complex. Future work will be directed at defining 
this epitope in terms of the sulfated and fucosylated constit- 
uents  that  are  present  within  the  O-linked  chains  of 
GIyCAM-1. 
MECA 79 blocks L-selectin  dependent lymphocyte binding 
to HEV in mouse lymph nodes and in human tonsils and 
lymph nodes (38, 40). Thus, the sulfation requirement for 
recognition of PNAd by this antibody, reinforces  the previous 
demonstration that sulfation is essential for HEV-ligand ac- 
tivity (34). It is important to note that MECA 79 staining 
is induced on venular endothelium in many chronic inflam- 
matory settings, including multiple cutaneous lesions, rheu- 
matoid synovium, lymphocytic thyroiditis, and inflammatory 
bowel diseases in human (40, 53); a DTH site in sheep (54); 
inflamed pancreatic acinar tissue in a IL-10 transgenic mouse 
model (55); inflamed pancreas in a IFN-'y transgenic mouse 
model (56); and spontaneously inflamed pancreatic islets and 
salivary glands in the nonobese diabetic (NOD) mouse (57, 
58). In the case of NOD mice, expression of the MECA 79 
epitope was shown to be associated with the expression of 
functional ligands for L-sdectin (57). It is also noteworthy 
that  strong metabolic incorporation of [3sS]SO4 has been 
seen, not only in HEV of rodent and human lymph nodes 
(27, 59), but also in HEV-like vessels that are induced at sites 
of chronic inflammation in both rodent and human (59, 60). 
Taken together, these findings raise that the possibility that 
sulfation, in addition to being essential for the function of 
HEV-ligands in secondary lymphoid organs, is also required 
for recognition of L-selectin ligands on blood vessels at sites 
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